Innovent Biologics, Sanofi to develop cancer medicines for China

Innovent Biologics, Sanofi to develop cancer medicines for China

News Source:- >> | Image Source:- >>

Innovent Biologics and Sanofi have announced a collaboration to bring innovative medicines to patients in China with difficult-to-treat cancers. Both companies are devoted to accelerating the development and commercialization of two key clinical-stage oncology assets from Sanofi: Phase III SAR408701 (tusamitamab ravtansine; anti-CEACAM5 antibody-drug conjugate) and Phase II SAR444245 (non-alpha IL-2), both of which are intended to be combined with sintilimab, the top checkpoint inhibitor in China. Sanofi will contribute $300 million to Innovent in addition to the collaboration and license agreement by subscribing for additional common shares. The agreement stipulates that Innovent will be responsible for tusamitamab’s development and exclusive commercialization in China for a variety of oncology-based purposes. Upon clearance, Sanofi will be eligible to receive royalties on the net sales of the product in China and development milestone payments of up to €80 million

=========================================================================================================

About Ingenious e-Brain:-

Ingenious e-Brain provides high-quality, customized, and cost-effective Technology Research, Business Research, and Intellectual Property Research solutions to industry leaders and innovative companies across the globe. Innovation, knowledge, and transparency form the basis of our company’s mission and vision. Along with cost benefits, we provide the highest quality results ensuring fool-proof confidentiality and security. We are an ISO-certified company with offices in India and USA.

Ingenious e-Brain has a strong team of analysts and subject matter experts with domain proficiency which is devoted to helping clients grow. Our highly qualified professionals offer tailored, value-added, and cost-effective services to our clients. We believe in building long-term relationships with our clients which include national and international corporations, Fortune 500 companies, the world’s leading research institutes and universities as well as independent inventors.

Get in Touch:-
India Office
207-208 Welldone TechPark, Sohna Road
Sector 48, Gurugram, Haryana 122018, India
+91 124 429 4218

Email:-
contact@iebrain.com

CONNECT With
our Experts








    "

    "